Categorized | All Episodes

May 31, 2011: FDA Rescinds Approval of Breast Cancer Drug

Senior Fellow Greg Conko breaks down the fight over Avastin, a drug used to treat several types of cancer. The FDA is poised to rescind Avastin’s approval for treating breast cancer. It will retain its approval for other cancers. This will make life difficult, and possibly shorter, for some breast cancer patients. Conko believes this battle boils down to one question: who decides which treatments patients can use? Will it be the FDA, or doctors and patients?

5 Responses to “May 31, 2011: FDA Rescinds Approval of Breast Cancer Drug”

  1. FAMEDS says:

    Have you heard of Freedom of Access to Medicines? The only non-profit org Fighting the FDA to continue to allow Avastin for 17,500 Women with Metastatic Breast Cancer currently Surviving on the Drug! Please sign and share the urgent petition: http://fameds.org/petition.php

Trackbacks/Pingbacks

  1. [...] Health and Illness,Healthcare,Personal Liberty,Podcast,Precaution & Risk,Regulation Tweet Have a listen here.Senior Fellow Greg Conko breaks down the fight over Avastin, a drug used to treat several types of [...]

  2. [...] A few weeks ago, I interviewed Greg about Avastin and the FDA here. [...]

  3. [...] thing as an average cancer patient.A few weeks ago, I interviewed Greg about Avastin and the FDA here.Tagged as: avastin, breast cancer, breast cancer treatments, FDA, Greg Conko, [...]


Subscribe

  • Subscribe with iTunes
  • Podcast Feed

More Info

Give Us Feedback

Send us your comments:
feedback@libertyweek.org